XML 36 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Information
6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information

Engineered
Materials
Acetate TowAcetyl
Chain
Other
Activities
EliminationsConsolidated
(In $ millions)
Three Months Ended June 30, 2022
Net sales948 119 1,456 — (37)(1)2,486 
Other (charges) gains, net— — — — 
Operating profit (loss)166 (1)429 (111)— 483 
Equity in net earnings (loss) of affiliates
53 — — 60 
Depreciation and amortization45 10 42 — 103 
Capital expenditures35 78 10 — 132 (2)
Three Months Ended June 30, 2021
Net sales
682 138 1,409 — (31)(1)2,198 
Other (charges) gains, net(1)— — (2)— (3)
Operating profit (loss)
123 24 516 (96)— 567 
Equity in net earnings (loss) of affiliates
32 — — 37 
Depreciation and amortization
35 43 — 91 
Capital expenditures
33 10 65 — 113 (2)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes an increase in accrued capital expenditures of $8 million and $3 million for the three months ended June 30, 2022 and 2021, respectively.

Engineered
Materials
Acetate TowAcetyl
Chain
Other
Activities
EliminationsConsolidated
(In $ millions)
Six Months Ended June 30, 2022
Net sales1,858 244 2,994 — (72)(1)5,024 
Other (charges) gains, net— — — — — — 
Operating profit (loss)290 928 (207)— 1,014 
Equity in net earnings (loss) of affiliates
102 — — 116 
Depreciation and amortization91 21 87 10 — 209 
Capital expenditures65 17 140 24 — 246 (2)
As of June 30, 2022
Goodwill and intangible assets, net
1,613 152 258 — — 2,023 
Total assets
5,702 1,136 4,537 1,338 — 12,713 
Six Months Ended June 30, 2021
Net sales
1,327 257 

2,465 

— (53)(1)3,996 
Other (charges) gains, net— — (3)— 
Operating profit (loss)
253 40 767 (167)— 893 
Equity in net earnings (loss) of affiliates
57 — — 66 
Depreciation and amortization
70 19 84 — 181 
Capital expenditures
56 21 98 11 — 186 (2)
As of December 31, 2021
Goodwill and intangible assets, net
1,714 154 279 — — 2,147 
Total assets
5,363 1,098 4,428 1,086 — 11,975 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $15 million and $16 million for the six months ended June 30, 2022 and 2021, respectively.